MIL-101-Derived Mesoporous Carbon Supporting Highly Exposed Fe Single-Atom Sites as Efficient Oxygen Reduction Reaction Catalysts
© 2021 Wiley-VCH GmbH.
Veröffentlicht in: | Advanced materials (Deerfield Beach, Fla.). - 1998. - 33(2021), 23 vom: 16. Juni, Seite e2101038 |
---|---|
1. Verfasser: | |
Weitere Verfasser: | , , , , |
Format: | Online-Aufsatz |
Sprache: | English |
Veröffentlicht: |
2021
|
Zugriff auf das übergeordnete Werk: | Advanced materials (Deerfield Beach, Fla.) |
Schlagworte: | Journal Article Fe single-atom catalysts MIL-101 mesoporous carbon oxygen reduction reaction zinc-air batteries |
Zusammenfassung: | © 2021 Wiley-VCH GmbH. Fe single-atom catalysts (Fe SACs) with atomic FeNx active sites are very promising alternatives to platinum-based catalysts for the oxygen reduction reaction (ORR). The pyrolysis of metal-organic frameworks (MOFs) is a common approach for preparing Fe SACs, though most MOF-derived catalysts reported to date are microporous and thus suffer from poor mass transfer and a high proportion of catalytically inaccessible FeNx active sites. Herein, NH2 -MIL-101(Al), a MOF possessing a mesoporous cage architecture, is used as the precursor to prepare a series of N-doped carbon supports (denoted herein as NC-MIL101-T) with a well-defined mesoporous structure at different pyrolysis temperatures. The NC-MIL101-T supports are then impregnated with a Fe(II)-phenanthroline complex, and heated again to yield Fe SAC-MIL101-T catalysts rich in accessible FeNx single atom sites. The best performing Fe SAC-MIL101-1000 catalyst offers outstanding ORR activity in alkaline media, evidenced by an ORR half-wave potential of 0.94 V (vs RHE) in 0.1 m KOH, as well as excellent performance in both aqueous primary zinc-air batteries (a near maximum theoretical energy density of 984.2 Wh kgZn -1 ) and solid-state zinc-air batteries (a peak power density of 50.6 mW cm-2 and a specific capacity of 724.0 mAh kgZn -1 ) |
---|---|
Beschreibung: | Date Revised 09.06.2021 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
ISSN: | 1521-4095 |
DOI: | 10.1002/adma.202101038 |